Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC

NCT02774187 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

247

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib
PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Folfox Protocol

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]